Furthermore, since insulin only is not the usual treatment for T2DM treatment, these patients might have had specific clinical conditions where this type of treatment was indicated, such as misdiagnosed type 1 diabetes, secondary insulin insufficiency or end-stage organ failure. This evidence concerns the gene INS and type 1 diabetes mellitus.